Literature DB >> 1319370

Characteristics and mechanism of glutamine-dipeptide absorption in human intestine.

H Minami1, E L Morse, S A Adibi.   

Abstract

Using in vivo and in vitro techniques, the mechanism by which intestinal mucosa obtains glutamine from luminal oligopeptides was investigated in humans. The rate of hydrolysis by mucosal brush border membrane was more than threefold greater for alanylglutamine than for glycylglutamine. Despite this difference, rates of dipeptide and amino acid disappearance during intestinal perfusion were greater from test solutions containing glycylglutamine than alanylglutamine. Furthermore, rates of intraluminal appearance of products of hydrolysis during the infusion of two dipeptides were similar and less than 5% of the disappearance rate of the parent dipeptide. In contrast to free glutamine, uptake of peptide-bound glutamine by brush border membrane vesicles was not inhibited by deletion of sodium or addition of free amino acids to the incubation medium but was inhibited by other oligopeptides and stimulated by a proton gradient. Inhibition constants for the saturable uptake of glycylglutamine and alanylglutamine by vesicles were not significantly different, suggesting similar affinities for the peptide transporter. It is concluded that in human intestine the predominant mechanism for assimilation of glutamine-dipeptides is absorption as intact dipeptide rather than hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319370     DOI: 10.1016/0016-5085(92)91088-l

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

Review 1.  Carrier-mediated intestinal transport of drugs.

Authors:  A Tsuji; I Tamai
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

2.  Characterisation of penicillin G uptake in human small intestinal brush border membrane vesicles.

Authors:  J F Poschet; S M Hammond; P D Fairclough
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 3.  Function, Regulation, and Pathophysiological Relevance of the POT Superfamily, Specifically PepT1 in Inflammatory Bowel Disease.

Authors:  Emilie Viennois; Adani Pujada; Jane Zen; Didier Merlin
Journal:  Compr Physiol       Date:  2018-03-25       Impact factor: 9.090

4.  H+/di-tripeptide transporter (PepT1) expression in the rabbit intestine.

Authors:  T C Freeman; B S Bentsen; D T Thwaites; N L Simmons
Journal:  Pflugers Arch       Date:  1995-07       Impact factor: 3.657

Review 5.  Intestinal absorption of peptide drugs: advances in our understanding and clinical implications.

Authors:  S M Catnach; P D Fairclough; S M Hammond
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

6.  Substrate upregulation of the human small intestinal peptide transporter, hPepT1.

Authors:  D Walker; D T Thwaites; N L Simmons; H J Gilbert; B H Hirst
Journal:  J Physiol       Date:  1998-03-15       Impact factor: 5.182

7.  Nicotinamide Adenine Dinucleotide (NAD+) and Enkephalinase Inhibition (IV1114589NAD) Infusions Significantly Attenuate Psychiatric Burden Sequalae in Substance Use Disorder (SUD) in Fifty Cases.

Authors:  Kenneth Blum; David Han; David Baron; Shan Kazmi; Igor Elman; Luis Llanos Gomez; Marjorie C Gondre-Lewis; Panyotis K Thanos; Eric R Braverman; Rajendra D Badgaiyan
Journal:  Curr Psychiatry Res Rev       Date:  2022-06-21

8.  Effects of n-3 fatty acid, fructose-1,6-diphosphate and glutamine on mucosal cell proliferation and apoptosis of small bowel graft after transplantation in rats.

Authors:  Xiao-Ting Wu; Jie-Shou Li; Xiao-Fei Zhao; Ning Li; Yu-Kui Ma; Wen Zhuang; Yong Zhou; Gang Yang
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

9.  A comparison of the effects of oral glutamine dipeptide, glutamine, and alanine on blood amino acid availability in rats submitted to insulin-induced hypoglycemia.

Authors:  Vania C Minguetti-Câmara; Any de C R Marques; Fabiana P M Schiavon; Vanessa R Vilela; Marcos L Bruschi; Roberto Barbosa Bazotte
Journal:  Nutrients       Date:  2014-10-21       Impact factor: 5.717

10.  Peptide-based enteral formula improves tolerance and clinical outcomes in abdominal surgery patients relative to a whole protein enteral formula.

Authors:  Ming-Yi Liu; Hsiu-Chih Tang; Shu-Hui Hu; Sue-Joan Chang
Journal:  World J Gastrointest Surg       Date:  2016-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.